Diabetes Mellitus Clinical Trial
Official title:
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
The purpose of this study is to determine if people with Diabetes Mellitus and peripheral
neuropathy can increase their activity (i.e. walking or stationary biking) and leg strength
without having an increase in foot problems compared to a group of people with diabetes and
peripheral neuropathy that do no exercise.
Our hypothesis is that the weight-bearing exercise group will achieve greater increases in
weight-bearing activity (i.e., increased steps/day and cumulative load) and leg strength
compared to the non-weight bearing exercise group and the non-exercising control group; and
there will be no clinically meaningful difference in incidence or indicators of foot lesions
between groups.
People with diabetes and peripheral neuropathy (DM+PN) have substantial lower extremity
impairments, functional limitations and disability. In addition to muscle weakness and poor
balance, they also are at high risk for foot ulcerations, especially if they have a history
of ulceration. Although there is a large and growing body of knowledge about the effect of
exercise on people with DM, there is little evidence about the effect of exercise in people
with DM+PN. Exercise is an important treatment component to help control the complications of
DM. The American Diabetes Association (ADA), and the American College of Sports Medicine
(ACSM)4 recommend that adults with DM participate in at least 30 minutes a day of
moderate-intensity physical activity that is consistent with a brisk walk. The ADA and ACSM,
however, discourage weight-bearing exercise for people with DM+PN due to risk of
exercise-induced foot injury. No data support this guideline to restrict those with DM+PN
from weight-bearing activity, and in fact, some evidence suggests that those with DM+PN who
are most active are least likely to develop skin breakdown. The Primary Goal of this proposal
is to conduct a pilot randomized prospective controlled clinical trial to determine if people
with DM+PN can benefit from a progressive weight-bearing exercise program to improve
impairments, functional limitations, disability, and pathophysiology without an increase in
skin breakdown or foot lesions. The benefits of a weight bearing program will be compared to
the benefits of a non weight bearing exercise program and to a non-exercising control group.
The results of this study also will help to determine if neuropathic skin and muscle can
adapt to increasing physical stress levels without injury which could have important
implications for weight-bearing and exercise guidelines for people with DM+PN.
A. SPECIFIC AIMS
Aim 1. Determine the effect of a weight-bearing exercise program compared to a non-weight
bearing exercise program and to a non-exercising control group on indicators of impairments,
functional limitations, disability, and pathophysiology in patients with DM+PN.
1. Measures of Impairment: Ankle joint range of motion, ankle plantar flexor and
dorsiflexor muscle strength (peak torque), muscle volume (magnetic resonance imaging),
and standing balance.
H1: Both exercise groups will show an improvement in ankle joint range of motion and
ankle plantar flexor / dorsiflexor muscle strength / volume compared to the
non-exercising control group, but only the weight-bearing exercise group will show an
improvement in standing balance because of exposure to challenging weight-bearing
activities.
2. Measures of Functional Limitations: Physical Performance Test, Foot & Ankle Ability
Measure.
H2: Both exercise groups will show improvement in the Physical Performance Test and Foot
& Ankle Ability Measure compared to the non-exercising control group, and the
weight-bearing exercise group will show greater improvements than the non-weight bearing
exercise group because of improved balance and exposure to challenging weight-bearing
activities.
3. Measures of Disability / Participation: Diabetes Symptom Checklist, Beck Depression
Inventory.
H3: Both exercise groups will show improved measures of disability compared to the
non-exercising control group, and the weight-bearing exercise group will show greater
improvements than the non-weight bearing exercise group because of improved ability to
participate in community activities which require weight-bearing and walking ability.
4. Measures of Pathophysiology: HbA1c, serum lipids, DXA (body composition), and body mass
index.
H4: Both exercise groups will show modest but statistically significant improvements compared
to the non-exercising control group in the above measures of pathophysiology.
Aim 2: Determine the effect of weight-bearing exercise program and non-weight bearing
exercise program compared to a control group on 1) daily step count (steps/day), 2) an
estimate of cumulative load (step count * plantar pressure integral), 3) unilateral increase
in surface foot temperature, and 4) incidence of foot lesions (digital photograph).
H5: The weight-bearing exercise group will achieve greater increases in weight-bearing
activity (i.e., increased steps/day and cumulative load) compared to the non-weight bearing
exercise group and the non-exercising control group; and there will be no clinically
meaningful difference in incidence or indicators of foot lesions between groups.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |